Patents Examined by David W Berke-Schlessel
  • Patent number: 11208647
    Abstract: The presently disclosed subject matter relates generally to the delivery of electrical stimuli via cell-penetrating nanoelectrodes. Such electrical stimuli leads to differentiation of cells, including but not limited to adipose derived stem cells, to neural lineage, specifically to neural cells.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: December 28, 2021
    Assignee: North Carolina Agricultural and Technical State University
    Inventors: Shyam Aravamudhan, Komal Garde
  • Patent number: 11191809
    Abstract: The present invention relates to a composition in powder form comprising probiotic bacteria and at least one iron-milk protein complex. Such iron-milk protein complex advantageously does not cause significant reduction in the viability of the bacteria and thus such iron source is advantageously used to fortify a composition in powder form comprising probiotic bacteria.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: December 7, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Bertrand Bourqui, Joeska Husny
  • Patent number: 11193947
    Abstract: Described herein are methods for assessing the risk of cardiovascular disease in a subject in need thereof by detecting the presence of one or more cleavage products of the one or more natriuretic peptides over a period of time, wherein the presence of one or more cleavage products is indicative of an increased risk of the subject developing cardiovascular disease. Provided herein are compositions and kits comprising a non-natural natriuretic peptide comprising one or more D-amino acids. Also provided herein are methods of diagnosing a subject for a disease and treating the subject for the disease, wherein the method comprises the use of a non-natural natriuretic peptide comprising one or more D-amino acids.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: December 7, 2021
    Assignee: CEDARS-SINAI MEDICAL CENTER
    Inventors: Shenyan Zhang, Koen Raedschelders, Jennifer Van Eyk
  • Patent number: 11186811
    Abstract: A process for fermenting syngas is provided which is effective for decreasing an amount of time needed to inoculate a main reactor. The process includes propagating a culture of acetogenic bacteria to provide an inoculum for a main reactor and fermenting syngas in the main reactor.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: November 30, 2021
    Inventors: Peter Simpson Bell, Ching-Whan Ko
  • Patent number: 11173185
    Abstract: Provided is a method of producing a culture product of a microorganism, for obtaining a culture product excellent in anti-inflammatory property in which a ratio between the production amounts of IL-10 and IL-12 (ratio of IL-10/IL-12) is large. Specifically, provided is a method of producing a culture product of Lactobacillus plantarum, including culturing Lactobacillus plantarum using a medium containing an unsaturated fatty acid ester until a time point at or before an end of a logarithmic growth phase, to thereby obtain a culture product of Lactobacillus plantarum. The unsaturated fatty acid ester is an ester formed through a reaction between a monovalent or polyvalent unsaturated fatty acid and a polyhydric alcohol, or a derivative of the ester. A preferred example of the unsaturated fatty acid ester is a monooleic acid ester.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: November 16, 2021
    Assignee: MEIJI CO., LTD.
    Inventors: Keisuke Furuichi, Takayuki Toshimitsu, Satoru Ozaki
  • Patent number: 11173184
    Abstract: The current invention concerns a new B. subtilis strain with strong inhibition of C. perfringens and its use as a probiotic.
    Type: Grant
    Filed: May 29, 2017
    Date of Patent: November 16, 2021
    Assignee: Evonik Operations GmbH
    Inventors: Daniel Petri, Stefan Pelzer, Jessica Kleinbölting, Stella Molck, Maike Kipker, Claudia Borgmeier, Sandra Herbold, Guido Meurer, Rose Whelan, Kiran Doranalli
  • Patent number: 11169140
    Abstract: An electrochemical device for diagnostic purposes, and particularly point-of-care diagnostic purposes, is capable of detecting quorum sensing molecules, such as AHL, within a biological sample with high precision. The device includes at least one reference electrode (RE), at least one counter electrode (CE), and two or more working electrodes (WEs). Each working electrode differs from the other working electrode(s) with respect to at least one of the following characteristics: surface area, size, material, and coating. The device also has a sample receiving area for receiving a biological sample, wherein the electrodes and the sample receiving area is fluidly connected, and a means for transferring the sample to the electrodes for measurement, and a means for displaying a result of the measurement.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: November 9, 2021
    Assignee: Danmarks Tekniske Universitet
    Inventors: Fatima Alzahra'a Alatraktchi, Winnie Edith Svendsen
  • Patent number: 11166991
    Abstract: The invention relates to a novel bacterial strain deposited with the CNCM under number 1-4969. This strain has properties that are useful in the treatment of respiratory disorders. The invention also relates to compositions and uses of said strain.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: November 9, 2021
    Assignee: Institut National De La Recherche Agronomique
    Inventors: Muriel Thomas, Aude Remot-Brizion, Philippe Langella
  • Patent number: 11162068
    Abstract: Disclosed is a method for manufacturing a composite nanofiber support and a fish collagen/synthetic polymer nanofiber support manufactured by the method, wherein the method comprises: a first step for dissolving a synthetic polymer in an organic solvent; a second step for dissolving a fish collagen in water to prepare an aqueous fish collagen solution; a third step for adding the aqueous fish collagen solution prepared in the second step to the synthetic polymer solution prepared in the first step, followed by mixing; and a fourth step for electrospinning the mixture solution prepared in the third step to manufacture a nanofiber support.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: November 2, 2021
    Assignee: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
    Inventors: Sik Yoon, Jong-Young Kwak, Song-Wan Jin, Young Hun Jeong, Chang Gun Kim, Da Jeong Choi, Hae Yeong Kang, Subhan Fazli, Muhamad Ikram
  • Patent number: 11162074
    Abstract: The invention relates to purified, tissue-specific progenitors, methods of making and using such tissue-specific progenitors.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: November 2, 2021
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Peiman Hematti, Jaehyup Kim
  • Patent number: 11155782
    Abstract: An object of the present invention is to provide a method capable of inexpensively and conveniently preparing cells having pluripotency and a very low risk of tumorigenic transformation.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: October 26, 2021
    Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Risa Okairi, Masuhiro Nishimura, Tamaki Wada
  • Patent number: 11155781
    Abstract: The present disclosure describes methods of maintaining the phenotype of differentiated cells. Generally, the natural environment of the body is replicated for the differentiated cell. The differentiated cell is plated on a cell culture substrate comprising a laminin, such as laminin-521 or laminin-511. The substrate may also contain a cadherin. This maintains the phenotype of the differentiated cell.
    Type: Grant
    Filed: November 14, 2016
    Date of Patent: October 26, 2021
    Assignee: BIOLAMINA AB
    Inventors: Karl Tryggvason, Karl Kristian Tryggvason, Anna Domogatskaya
  • Patent number: 11136614
    Abstract: Methods for seeding live cells onto spatially defined regions of a substrate including multiple features (e.g., microwells or other microenvironments) utilize a stencil embodied in a hole-defining sacrificial film. A sacrificial film devoid of holes may be applied over features of a substrate, and a hole generating mechanism (e.g., hot needle or laser) aligned with features may be used to define holes in the film. Alternatively, holes may be predefined in a sacrificial film to form a stencil, and the stencil may be assembled to the substrate with the holes registered with features thereof. Thereafter, cells are seeded through holes in the film. Seeded cells are subject to incubation, further processing, and/or performance of one or more assays, and the hole-defining sacrificial film (stencil) may be removed.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: October 5, 2021
    Assignee: Arizona Board of Regents on Behalf of Arizona State University
    Inventors: Jacob Messner, Clifford Anderson, Honor Glenn, Kristen Lee, Mark Richards, Laimonas Kelbauskas, Kimberly Bussey, Deirdre Meldrum
  • Patent number: 11135276
    Abstract: A method for producing soluble PDIA2, compositions containing it, and methods for its use.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: October 5, 2021
    Assignee: Imam Abdulrahman Bin Faisal University
    Inventor: Manal Abdullah Alsaloum
  • Patent number: 11137327
    Abstract: This invention relates to devices and methods for purifying, detecting and using biological cells. A variety of cell types including viable tumor, stem, immune and sperm cells can be purified from a complex biological sample using a column, including a pipette tip column. Methods of the invention can aid research, diagnosis and treatment of cancer. Purified viable cells can be detected on the column or eluted from the column and detected. Cells on a column can be used as a stationary phase for liquid chromatography. Cells may be removed, recovered and analyzed.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: October 5, 2021
    Inventor: Douglas T. Gjerde
  • Patent number: 11129400
    Abstract: A method for ecological utilization of silver carp, including the pretreatment of silver carp and the process of making canned fish surimi. The fish meat of silver carp is processed canned surimi. The fish heads and bones are heated and undergo enzymatic hydrolysis by enzymes, and the residues of the filtration are prepared for fish bone powder. A filtration membrane is used to reduce the volume of the filtrate to 50% of fish surimi and then the filtrate is frozen to ice. The frozen part can be added to fish surimi. The transparent part from membrane filtration was used to produce protein powder or ingredients for beverages. Fish offal can be used to produce protein liquid fertilizer. Fish scales and skins can be used to produce collagen. The method adopts ecological utilization, which makes the silver carp meat used effectively, including its processed wastes. The method is a closed cycle process such that that no pollutants or wastes are discharged during the process.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: September 28, 2021
    Inventors: Junjie Zhang, Gongcheng Wang, Yingdong Zhang, Rui Duan, Feiwen Mao, Boyan Zhang
  • Patent number: 11130939
    Abstract: The present disclosure relates to strains for degrading ethylene oxide and degradation agents comprising the same, wherein the strains are Acetobacter peroxydans EO-01 strain with Deposit number of CGMCC No. 18431; Lactobacillus fermentum EO-02 strain with Deposit number of CGMCC No. 18432; or Bacillus subtilis EO-03 strain with Deposit number of CGMCC No. 18433. The strains are capable of safely and efficiently degrading ethylene oxide. The present disclosure also provides a method for purifying and producing strains that can degrade ethylene oxide, and a method for biodegrading ethylene oxide.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: September 28, 2021
    Assignees: CHIO KANG MEDICAL, INC., QIAOKANG BIOTECH (GUANGDONG) CO., LTD.
    Inventors: Dongxin Hou, Jianlong Xue, Jiali Lin, Xin Yin, Yecheng He, Shengwei Hu, Qinghua Xiao, Liqing Zhu, Lixiong Feng
  • Patent number: 11124761
    Abstract: Embodiments of the current invention include a hydrogel formed from crosslinked polyethylene glycol into which acrylated glucose oxidase has been immobilized through crosslinking to the gel. These hydrogels can be used to create hypoxia under ambient conditions for at least 72 hours and can be used to create hypoxic gradients. These embodiments permit the study of cells under a variety of hypoxic conditions.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: September 21, 2021
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Chien-Chi Lin, Camron Scott Dawes, Heiko Konig
  • Patent number: 11124785
    Abstract: There are gluten-degrading enzymes found in Rothia species bacteria that are subtilisins that belonging to the S8A family of serine protease family. The Rothia sp. derived subtilisin-like enzymes have the conserved catalytic triad composed of a Ser, His, and Asp residues that is characteristic of the serine protease family. The Rothia subtilisin enzymes are potent at cleaving proline-containing proteins, cleaving the second peptide bond after proline in the XPX1 motif, where X is any amino acid, P is proline and X1 is a hydrophobic amino acid, e.g. the XPQ motif, where Q is glutamine. Embodiments herein provide isolated enzyme compositions and formulations comprising subtilisins gluten-degrading enzyme from a Rothia species bacteria. Also provided herein are methods of treatment of celiac disease or a related disorder, treatment of gluten-containing foodstuff, degrading and/or detoxifying gluten comprising the subtilisins gluten-degrading enzyme and/or compositions.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: September 21, 2021
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Eva J. Helmerhorst, Guoxian Wei, Na Tian, Detlef Schuppan
  • Patent number: 11116224
    Abstract: The present specification discloses pest control compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a population of invertebrate pests from a mammal, location, plant, structure treated of such pest control compositions.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: September 14, 2021
    Assignee: Neozyme International, Inc.
    Inventors: Parker Dale, Parker David Dale